UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation

Scientific reports, 2024-09, Vol.14 (1), p.21481-7, Article 21481

2024

Volltextzugriff (PDF)

Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2020-09, Vol.55 (9), p.1851-1853

2020

Volltextzugriff (PDF)

Meibography and meibomian gland measurements in ocular graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.961-967

2015

Volltextzugriff (PDF)

Insulin eye drops for severe refractory chronic ocular graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2024-07, Vol.59 (7), p.1031-1033

2024

Volltextzugriff (PDF)

Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2018-01, Vol.53 (1), p.52-57

2018

Volltextzugriff (PDF)

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

British journal of dermatology (1951), 2008-04, Vol.158 (4), p.659-678

2008

Volltextzugriff (PDF)

P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A28-A29

2024

Volltextzugriff (PDF)

S235: A TWO‐PART, SINGLE‐ AND TWO‐ARM RANDOMIZED, OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES

HemaSphere, 2022-06, Vol.6, p.136-137

2022

Volltextzugriff (PDF)

OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1448: LONG‐TERM SURVIVORS AFTER FAILURE OF CAR‐T CELL THERAPY FOR R/R LARGE B‐CELL LYMPHOMA (LBCL): A GLA/DRST STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1331-1332

2022

Volltextzugriff (PDF)

P1184: PHASE I TRIAL OF MB‐CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B‐CELL NON‐HODGKIN LYMPHOMA: 2 YEAR FOLLOW‐UP REPORT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1070-1071

2022

Volltextzugriff (PDF)

Predicting survival using clinical risk scores and non-HLA immunogenetics

Bone marrow transplantation (Basingstoke), 2015-11, Vol.50 (11), p.1445-1452

2015

Volltextzugriff (PDF)

P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA AFTER CD19 CAR T‐CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1330-1331

2022

Volltextzugriff (PDF)

STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis

Leukemia, 2005-06, Vol.19 (6), p.936-944

2005

Volltextzugriff (PDF)

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Blood, 2022-07, Vol.140 (4), p.349-358

2022

Volltextzugriff (PDF)

Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience

Annals of hematology, 2015-10, Vol.94 (10), p.1717-1725

2015

Volltextzugriff (PDF)

Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia

International journal of immunogenetics, 2016-12, Vol.43 (6), p.404-412

2016

Volltextzugriff (PDF)

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy

Leukemia, 2011-05, Vol.25 (5), p.880-883

2011

Volltextzugriff (PDF)

Allogene Blutstammzelltransplantation – ein Überblick

Klinische Monatsblätter für Augenheilkunde, 2015-05, Vol.232 (5), p.641-646

2015

Volltextzugriff (PDF)

REAL-WORLD DATA SUGGEST EFFECTIVNESS OF THE ALLOGENEIC MESENCHYMAL STROMAL CELLS PREPARATION MSC-FFM IN RUXOLITINIB-REFRACTORY OR -INTOLERANT ACUTE GRAFT-VERSUS-HOST DISEASE

Cytotherapy (Oxford, England), 2024-06, Vol.26 (6), p.S24-S24

2024

Volltextzugriff (PDF)

STAT3 is constitutively activated in Hodgkin cell lines

Blood, 2001-08, Vol.98 (3), p.762-770

2001

Volltextzugriff (PDF)

P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A17-A17

2020

Volltextzugriff (PDF)

191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

Immuno-oncology technology, 2022-12, Vol.16, p.100303, Article 100303

2022

Volltextzugriff (PDF)

46 Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - clinical efficacy and immunological results of a phase I study

European journal of cancer supplements, 2010, Vol.8 (7), p.23-24

2010

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(37)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Hematology
(13)
Adult
(11)
Middle Aged
(10)
Oncology
(10)
Stem Cell Transplantation
(10)
Transplantation
(10)
Biological And Medical Sciences
(9)
Female
(9)
Immunology
(9)
Male
(9)
Medical Sciences
(9)
Aged
(6)
Stem Cells
(6)
Biophysics
(5)
Graft-Versus-Host Reaction
(5)
Hematologic And Hematopoietic Diseases
(5)
Risk Factors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation

Meibography and meibomian gland measurements in ocular graft-versus-host disease

Insulin eye drops for severe refractory chronic ocular graft-versus-host disease

Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation

S235: A TWO‐PART, SINGLE‐ AND TWO‐ARM RANDOMIZED, OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES

OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS

P1448: LONG‐TERM SURVIVORS AFTER FAILURE OF CAR‐T CELL THERAPY FOR R/R LARGE B‐CELL LYMPHOMA (LBCL): A GLA/DRST STUDY

P1184: PHASE I TRIAL OF MB‐CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B‐CELL NON‐HODGKIN LYMPHOMA: 2 YEAR FOLLOW‐UP REPORT

Predicting survival using clinical risk scores and non-HLA immunogenetics

P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA AFTER CD19 CAR T‐CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience

Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy

Allogene Blutstammzelltransplantation – ein Überblick

REAL-WORLD DATA SUGGEST EFFECTIVNESS OF THE ALLOGENEIC MESENCHYMAL STROMAL CELLS PREPARATION MSC-FFM IN RUXOLITINIB-REFRACTORY OR -INTOLERANT ACUTE GRAFT-VERSUS-HOST DISEASE

STAT3 is constitutively activated in Hodgkin cell lines

P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation

191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

46 Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - clinical efficacy and immunological results of a phase I study

Suchergebnisse filtern